Hepatobiliary Cancer Coverage from Every Angle
Editor:
Al B. Benson III, MD, FACP, FASCO
Advertisement
Advertisement

Published Medical Literature

How Lenvatinib Compares With Other Therapies for Nonviral, Unresectable Liver Cancer
Role of Circadian Clock Protein Regulation in the Proliferation of Liver Cancer
New Program Aims to Narrow Education Gap Among Patients With Cholangiocarcinoma
Nivolumab After Selective Internal Radiotherapy for Locally Advanced Liver Cancer
Evaluating the Role of BNIP3 in Hepatocellular Carcinoma Development and Progression
After a Diagnosis of Cholangiocarcinoma: Benefit of Well-Balanced Diet and Exercise
Researchers Find Certain Amino Acids May Be Potential Biomarkers of Hepatocellular Carcinoma
Targeted Agent Under Study in Treatment of Rare Liver Cancer
Is Gallbladder Cancer Overdiagnosed in Regions With a High Incidence?
Robotic Versus Open Liver Resection for Hepatocellular Carcinoma
Is IMRT Before Surgery of Benefit in Patients With Centrally Located Liver Cancer?
Triplet Combination Therapy Under Study in High-Risk Advanced Liver Cancer
Perihilar Cholangiocarcinoma: Preoperative Risk Factors for Early Recurrence
Dynamic Role of Hepatic Stellate Cell Subpopulations During Hepatocarcinogenesis
Novel Therapy Using Nanoparticles Under Study in Hepatocellular Carcinoma
Extracellular Vesicle–Based Protein Assay May Enable Earlier Detection of Hepatocellular Carcinoma
Does Exposure to Certain Industrial Chemicals Increase the Risk for Liver Cancer?
Atypical Growth Factor Induction of Circular Dorsal Ruffles in Hepatocellular Carcinoma Cells
Can Biomarkers Predict Outcomes With Nivolumab in Refractory Biliary Tract Cancer?
Rare Case of Liver Cancer With Neuroendocrine Differentiation: Focus on Use of Tumor Organoids
Systemic Immune Inflammation Index: Prognostic Tool in Extrahepatic Cholangiocarcinoma?
Identifying Risk Factors for Early Death in Patients With Advanced Hepatocellular Carcinoma
Machine Learning Applications in Gallbladder Cancer Prognosis
Impact of Chorion-Derived Mesenchymal Stem Cells on the Growth of Cholangiocarcinoma
Adding Durvalumab to Standard-of-Care Chemotherapy for Advanced Biliary Tract Cancer
Reserarch Reveals Prognostic Potential of Four Pyroptosis-Related Genes in Hepatocellular Carcinoma
Preclinical Data Point to GCN2 Inhibition as a Potential Treatment Strategy in Hepatocellular Carcinoma
Novel Nomogram May Help to Predict Cancer Risk and Survival Among Some Patients With Liver Cancer
Consider the Intestinal Environment in Predicting Immunotherapy Response in Liver Cancer
Can Kinome Profiling Influence Treatment Decisions for Patients With Cholangiocarcinoma?
Copyright © 2023 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.